Orvieto Raoul
Infertility and IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center (Tel Hashomer), Ramat Gan, 52621, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Ovarian Res. 2015 Nov 4;8:69. doi: 10.1186/s13048-015-0198-3.
Recently, several new promising modifications have been introduced to clinical practice that may simplify and optimize IVF outcome. In the present opinion paper we present a simplified approach to controlled ovarian hyperstimulation protocol (COH), which combines the benefits of the ultrashort flare GnRH agonist/GnRH antagonist protocol and the personalized tailored mode and timing of ovulation triggering, aiming to improve IVF outcome while eliminating of severe OHSS.In patients at risk to develop severe ovarian hyperstimulation syndrome (OHSS), GnRH agonist (GnRHa) trigger if offered for final follicular maturation. While in those achieving ≥20 oocytes, the freeze all policy with the subsequent frozen-thawed embryo transfers (ET) is recommended, in those where less than 20 oocytes are retrieved, patients are re-evaluated 3 days after oocyte retrieval (day of ET) for signs of early moderate OHSS. If no early signs of OHSS developed, one embryo was transferred, and the patients are instructed to inject 1500 IU of HCG. In cases where signs of early moderate OHSS appear, the freeze all policy is recommended.In Patients not at risk to develop severe OHSS- three different modes of concomitant administration of both GnRHa and a standard bolus of hCG (5000-10,000 units) prior to oocyte retrieval were suggested. Standard hCG dose concomitant with GnRHa (dual trigger), 35-37 h before oocyte retrieval is offered to normal responders patients, resulting in improved oocyte/embryo quality and IVF outcome. GnRHa 40 h and standard hCG added 34 h prior to oocyte retrieval (double trigger), respectively are offered to patients demonstrating abnormal final follicular maturation despite normal response to COH. The double trigger results in significantly higher number of oocytes retrieved, higher proportions of the number of oocytes retrieved to the number of follicles >10 mm and >14 mm in diameter on day of hCG administration, higher number of MII oocytes and proportion of MII oocytes per number of oocytes retrieved, with the consequent significantly increased number of top-quality embryos, as compared to the hCG-only trigger cycles. Standard hCG dose concomitant with GnRHa (dual trigger), 34 h before oocyte retrieval should be offered to poor responders patients, aiming to overcome premature luteinization, while achieving high yield of mature oocytes.Further studies are required to support this new concept prior to its implementation as a universal COH protocol to IVF practice.
最近,临床实践中引入了几种新的有前景的改良方法,可能会简化并优化体外受精(IVF)的结果。在本观点论文中,我们提出了一种简化的控制性卵巢过度刺激方案(COH)方法,该方法结合了超短激发GnRH激动剂/ GnRH拮抗剂方案的优点以及个性化定制的排卵触发模式和时间,旨在改善IVF结果,同时消除严重的卵巢过度刺激综合征(OHSS)。对于有发生严重OHSS风险的患者,若进行最终卵泡成熟,则采用GnRH激动剂(GnRHa)触发。对于获得≥20个卵母细胞的患者,建议采用全冷冻策略及随后的冻融胚胎移植(ET);对于获得少于20个卵母细胞的患者,在取卵后3天(ET日)重新评估是否有早期中度OHSS的迹象。如果没有出现OHSS的早期迹象,则移植一枚胚胎,并指导患者注射1500IU的HCG。若出现早期中度OHSS的迹象,则建议采用全冷冻策略。对于没有发生严重OHSS风险的患者,建议在取卵前采用三种不同的同时给予GnRHa和标准剂量HCG(5000 - 10,000单位)推注的模式。在取卵前35 - 37小时,将标准HCG剂量与GnRHa同时给予(双重触发)正常反应者患者,可改善卵母细胞/胚胎质量和IVF结果。对于尽管对COH反应正常但最终卵泡成熟异常的患者,分别在取卵前40小时给予GnRHa和在取卵前34小时添加标准HCG(双重触发)。与仅使用HCG触发的周期相比,双重触发导致获得的卵母细胞数量显著增加,在给予HCG当天,获得的卵母细胞数量与直径>10mm和>14mm卵泡数量的比例更高,MII期卵母细胞数量和每获得的卵母细胞中MII期卵母细胞的比例更高,从而显著增加了优质胚胎的数量。对于反应不良的患者,应在取卵前34小时将标准HCG剂量与GnRHa同时给予(双重触发),旨在克服过早黄素化,同时获得高产的成熟卵母细胞。在将这一新概念作为通用的COH方案应用于IVF实践之前,需要进一步的研究来支持它。